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It is well known that a variety of drugs, particularly chlorpromazine,1 2 hydralazine,25 and procainamide,68 are responsible for the development not only of a variety of immunological abnormalities but also for the appearance of a drug induced lupus syndrome. Immunological abnormalities, in particular, positive tests for antinuclear antibodies, may be seen in 50-74% of asymptomatic patients treated with procainamide for longer than two months. With procainamide treatment a much smaller percentage of patients will develop drug induced lupus than those treated with chlorpromazine. The production of coagulation abnormalities such as 'lupus anticoagulants' is even rarer, particularly in the absence of other manifestations of drug induced lupus.917
We record a patient who developed drug induced lupus and anticardiolipin antibodies which were associated with multiple pulmonary thromboemboli. All hospital for evaluation of fever, pleuritic chest pains with bilateral effusions, and weight loss. Three years before admission treatment with procainamide had been started for management of ventricular arrythmias. About one year later he developed symmetrical proximal myalgias and muscle weakness accompanied by inflammatory arthritis of the small joints of the hands. He was treated with several antiinflammatory drugs, including naproxen, indomethacin, and ibuprofen, with no significant relief.
Prednisolone was prescribed in doses up to 40 mg daily, with dramatic response. Two months before admission to hospital the prednisolone was discontinued because of the occurrence of hyperglycaemia. The patient then developed profound proximal muscle weakness, fever to 38-80C accompanied by chills, a 20% weight loss over two months, fatigue, depression, and anorexia. Two weeks before admission to hospital the procainamide was discontinued. Because of severe pleuritic chest pains and chest x ray findings of bilateral pleural effusions with a minimal left lower lobe infiltrate the patient was admitted. While in hospital the patient was noted to have acute episodes of chest discomfort and shortness of breath, and on one occasion this was accompanied by peripheral cyanosis. A pulmonary perfusion scan showed multiple perfusion defects in both lungs, in areas where the chest x ray appeared normal. The study was incomplete as the patient was 232 unable to tolerate the ventilation mask, but the radiological impression was of the high probability of multiple pulmonary emboli (Fig. 1) . A The patient was initially treated with heparin followed by warfarin sodium for three months. 31 and polyneuropathy32 have also been reported. Although the antinuclear antibodies from most patients with drug induced lupus react with denatured single stranded DNA only, autoantibodies to native double stranded DNA may be detected in patients who develop drug induced lupus with procainamide treatment, as in our patient.32 34 This has also been seen in patients treated with phenylbutazone.35 Antibodies to ribonucleoprotein may be induced by procainamide in most patients soon after the start of treatment. These, however, disappear after long term treatment, and antibodies to extractable nuclear antigens never appear. The antinuclear antibodies are homogeneous in pattern and directed mainly at histones rather than at RNA/DNA and the wide variety of other nonhistone proteins such as occur in idiopathic systemic lupus erythematosus. The antinuclear antibodies are specifically directed against the H2A-H2B complex in 50% of symptomatic patients. 36 Circulating immune complexes may be detected in a higher proportion of patients receiving procainamide even in the absence of drug induced lupus,37 and hypocomplementaemia has also been noted. Hypocomplementaemia is not usually seen in drug induced lupus but has been recorded in patients receiving procainamide and in those receiving hydralazine. 38 This hypocomplementaemia has been shown to be due to the presence of null alleles at the C4 locus.39 40 Our patient also developed hypocomplementaemia (low C4) Polycryoglobulinaemia may also occur. 41 Generally, the presence of antiphospholipid antibodies-for example, anticardiolipin antibodies, in drug induced lupus has been associated with increases of the IgM isotype and is usually not associated with thrombotic complications.42 A few exceptions have been recorded as shown by the present case and in three previous case reports. 3 
